Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

General Information and Reorganization Transaction - Additional Information (Details)

v3.23.1
General Information and Reorganization Transaction - Additional Information (Details) - USD ($)
12 Months Ended
Jul. 02, 2021
Mar. 31, 2023
Mar. 31, 2022
Disclosure of reclassifications or changes in presentation [line items]      
Accumulated deficit   $ 11,794,460 $ 6,336,966
Net loss   5,457,763 1,749,870
Proceeds from issuing shares   $ 13,654,347 519,613
IPO      
Disclosure of reclassifications or changes in presentation [line items]      
Proceeds from issuing shares     $ 13,688,952
Virax Biolabs Group Limited      
Disclosure of reclassifications or changes in presentation [line items]      
Date of incoporation   Sep. 02, 2021  
Virax Biolabs (UK) Limited      
Disclosure of reclassifications or changes in presentation [line items]      
Date of incoporation   Aug. 19, 2021  
Virax Biolabs HKCo Limited      
Disclosure of reclassifications or changes in presentation [line items]      
Date of incoporation   Apr. 14, 2020  
Virax Immune T- Cell Medical Device Company Limited      
Disclosure of reclassifications or changes in presentation [line items]      
Date of incoporation   Jan. 16, 2017  
Virax Biolabs Pte. Limited      
Disclosure of reclassifications or changes in presentation [line items]      
Date of incoporation   May 04, 2013  
Virax Biolabs Group Limited      
Disclosure of reclassifications or changes in presentation [line items]      
Percentage of capital owned 95.65%    
Third Party Shareholders      
Disclosure of reclassifications or changes in presentation [line items]      
Percentage of capital owned 4.35%    
Logico Bioproduct Corp      
Disclosure of reclassifications or changes in presentation [line items]      
Date of incoporation   Jan. 21, 2011  
Shanghai Xitu Consulting Co., Limited      
Disclosure of reclassifications or changes in presentation [line items]      
Date of incoporation   Oct. 27, 2017